New research may lead to a vaccine against severe diarrhea (opens in new tab)

Research led by the University of Bergen (UiB) and NORCE may help pave the way for a new vaccine targeting one of the world's leading causes of severe diarrheal disease. The technology has now been licensed to the international vaccine company Valneva, which will take the work forward toward a potential future vaccine.